FR2887151A1 - Use of a homeopathic insulinum stock (I) to prepare homeopathic medicaments to treat viral infections due to herpes virus, papilloma virus and retrovirus - Google Patents

Use of a homeopathic insulinum stock (I) to prepare homeopathic medicaments to treat viral infections due to herpes virus, papilloma virus and retrovirus Download PDF

Info

Publication number
FR2887151A1
FR2887151A1 FR0506208A FR0506208A FR2887151A1 FR 2887151 A1 FR2887151 A1 FR 2887151A1 FR 0506208 A FR0506208 A FR 0506208A FR 0506208 A FR0506208 A FR 0506208A FR 2887151 A1 FR2887151 A1 FR 2887151A1
Authority
FR
France
Prior art keywords
homeopathic
insulinum
prepare
retrovirus
viral infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0506208A
Other languages
French (fr)
Other versions
FR2887151B1 (en
Inventor
Christian Marcel Gus Lantenois
Edgard Skrzypczak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0506208A priority Critical patent/FR2887151B1/en
Publication of FR2887151A1 publication Critical patent/FR2887151A1/en
Application granted granted Critical
Publication of FR2887151B1 publication Critical patent/FR2887151B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Abstract

Use of a homeopathic insulinum stock (I) to prepare homeopathic medicaments to treat viral infections due to herpes virus, papilloma virus and retrovirus of the RNA type. ACTIVITY : Virucide. No biological data given. MECHANISM OF ACTION : None given.

Description

La présente invention concerne la nouvelle utilisation d'une soucheThe present invention relates to the novel use of a strain

homéopathiquehomeopathic

en hautes dilutions pour la préparation de médicaments homéopathiques, seule ou associée, et son mode de préparation, ceux-ci ayant une action active sur les Herpesviridae, sur les papillomavirus, et sur les Retroviridae de type ARN Les préparations homéopathiques qui la contiennent seule ou associée se présentent sous forme de granules, doses, ampoules, gouttes, suppositoires, pommade, collyre, spray nasal ou pharyngé, pour être pris par la voie orale, injectable, rectale, cutanée, oculaire ou nasale et sont destinées à traiter l'herpès cutané, notamment labial et génital, le zona cutané, notamment ophtalmique, les verrues, et les affections dues aux rétrovirus de type RNA notamment dues à l' HN.  in high dilutions for the preparation of homeopathic medicinal products, alone or in combination, and its method of preparation, these having an active action on Herpesviridae, on papillomaviruses, and on RNA-type Retroviridae Homeopathic preparations containing it alone or associated in the form of granules, doses, ampoules, drops, suppositories, ointment, eye drops, nasal spray or pharyngeal, to be taken orally, injectable, rectal, cutaneous, ocular or nasal and are intended to treat herpes cutaneous, especially labial and genital, zoster cutaneous, including ophthalmic, warts, and conditions due to retrovirus type RNA especially due to the HN.

Les propriétés particulières nouvelles de cette souche homéopathique dans les médicaments homéopathiques préparées avec celle-ci seule ou associée, apparaissent suite à la montée en hautes dilutions selon un protocole opératoire de fabrication original qui lui confère un haut pouvoir de soin sans effet secondaire sur les affections liées i5 au virus de l'herpès, à celui du zona, et à ceux des verrues, et un pouvoir neutralisant et inhibiteur sur le HIV.  The particular novel properties of this homeopathic strain in homeopathic medicines prepared with it alone or in combination, appear following the rise in high dilutions according to an original manufacturing protocol which gives it a high level of care with no side effect on the affections linked to the herpes virus, shingles, and warts, and a neutralizing and inhibiting power on HIV.

La souche homéopathique, pour caractériser l'invention est insulinum, la mise en hautes dilutions homéopathiques lui confère et font apparaître dans les médicaments homéopathiques préparés avec celle-ci, seule ou associée des propriétés antivirales contre les Herpesviridae, sur les papillomavirus, et sur les Retroviridae, ces virus ont en commun certains caractères, ce sont des virus à DNA et à ce titre ils sont sensibles à insulinum en hautes dilutions homéopathiques qui, dans les médicaments homéopathiques préparés avec celle-ci, perturbe le métabolisme du DNA viral. Tous codent pour une DNA polymérase virale, cible d'insulinum en hautes dilutions homéopathiques.  The homeopathic strain, to characterize the invention is insulinum, the setting in high homeopathic dilutions confers and makes it appear in homeopathic medicines prepared with it, alone or associated with antiviral properties against Herpesviridae, on papillomaviruses, and on Retroviridae, these viruses have in common certain characters, they are DNA viruses and as such they are sensitive to insulinum in high homeopathic dilutions which, in homeopathic medicines prepared with it, disrupts the metabolism of the viral DNA. All encode a viral DNA polymerase, an insulin target in high homeopathic dilutions.

Son mode opératoire de fabrication non limitatif est basé, par exemple pour illustrer l'invention, sur la méthode dite Korsakovienne, et ses hautes dilutions non limitatives pour illustrer l'invention seront comprises entre i K et i 000 000 k L' activité anti-virale d'insulinum pour caractériser l'invention est obtenue par ses hautes dilutions homéopathiques, réalisées en utilisant par exemple le mode opératoire suivant.  Its non-limiting manufacturing procedure is based, for example to illustrate the invention, on the so-called Korsakovian method, and its high non-limiting dilutions to illustrate the invention will be between 1 K and 1,000,000 K. Viral insulinum to characterize the invention is obtained by its high homeopathic dilutions, made using, for example, the following procedure.

Le mode opératoire, selon l'invention, est constitué par des dilutions successives, dites Korsakoviennes, d'insulinum avec des énergisations spécifiques sur une pierre fossilisée toutes les 1000 à Io 000 dynamisations, dans un même et unique flacon, dont le contenu et lui-même servent en finalité à l'imprégnation des granules, doses, ampoules, gouttes, suppositoires, solutions stériles, spray nasal ou pharyngé, collyres et pommades.  The procedure according to the invention is constituted by successive Korsakovian dilutions of insulinum with specific energizations on a fossilized stone every 1000 to 1000 revolutions, in one and the same bottle, the contents of which and -even serve in the end impregnation of granules, doses, ampoules, drops, suppositories, sterile solutions, nasal spray or pharyngeal, eye drops and ointments.

A titre d'illustration de l'invention on indiquera ci-après des exemples non limitatifs de dosages d'insulinum en hautes dilutions homéopathiques présents dans des préparations de médicaments homéopathiques sous une forme non limitative, seule ou associée, et ses posologies dans l' utilisation conforme à l'invention, notons que dans le mode opératoire de sa fabrication, le principe de la méthode korsakovienne et ses dilutions en K ou korsakoviennes est non limitatif et pourra être substituée par celle dite hanemanienne et ses dilutions en CH ou centésimales.  As an illustration of the invention will be given hereinafter non-limiting examples of insulinum assays in high homeopathic dilutions present in homeopathic drug preparations in a non-limiting form, alone or in combination, and its dosages in the use in accordance with the invention, note that in the procedure of its manufacture, the principle of the korsakovian method and its K or korsakovian dilutions is non-limiting and may be substituted by the so-called Hanemanian and its dilutions in CH or centesimal.

Exemple non limitatif de la présentation d'un médicament homéopathique sous forme de granules contenant insulinum avec ses indications spécifiques, Io son dosage, sa composition et sa posologie -ZONA Cutané Insulinum en 50 000 K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue toutes les 2 heures pendant io jours 15 puis 3 à 4 fois par jour pendant 15 jours ZONA Ophtalmique Insulinum en lo0 00o K sous la forme non limitative de granules homéopathiques 5 granules à laisser fondre sous la langue toutes les 2 heures pendant io jours puis 3 fois par jour pendant 15 jours HERPES Labial ou Bouton de Fièvre Insulinum en 50 000 K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue toutes les 3 heures pendant 7 jours - HERPES génital Insulinum en lo0 00o K sous la forme non limitative de granules homéopathiques 25 5 granules à laisser fondre sous la langue toutes les 3 heures pendant 15 jours - VERRUES Insulinum en 10 00o K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue 3 fois par pendant 1 mois - INFECTIONS à RETROVIRUS Insulinum en 1000 00o K sous la forme non limitative de granules homéopathiques Posologie et durée du traitement à adapter selon la charge virale objectivée par les dosages sanguins des lymphocytes T4 3 2887151  Non-limiting example of the presentation of a homeopathic medicine in the form of granules containing insulinum with its specific indications, Io its dosage, composition and dosage-ZONA Cutaneous Insulinum in 50 000 K in the non-limiting form of homeopathic granules 3 granules to let it melt under the tongue every 2 hours for 10 days 15 then 3 to 4 times a day for 15 days ZONA Ophthalmic Insulinum lo 0 00o K in the non-limiting form of homeopathic granules 5 granules to be melted under the tongue every 2 hours for 10 days then 3 times a day for 15 days HERPES Labial or Insulinum Fever Button in 50 000 K in the non-limiting form of homeopathic granules 3 granules to let melt under the tongue every 3 hours for 7 days - HERPES genital Insulinum in lo0 00o K in the non-limiting form of homeopathic granules 25 granules to be melted under the tongue every 3 hours 15 days - LAMPS Insulinum in 10 00o K in the non-limiting form of homeopathic granules 3 granules to let melt under the tongue 3 times per month for 1 month - RETROVIRUS INFECTIONS Insulinum in 1000 00o K in the non-limiting form of homeopathic granules Dosage and duration of the treatment to be adapted according to the viral load objectified by the blood tests of the T4 lymphocytes 2887151

Claims (2)

REVENDICATIONS 1 ) Utilisation d'une souche homéopathique d' insulinum pour préparer des médicaments homéopathiques destinées à soigner les infections virales dues aux Herpesviridae, aux papillomavirus, et aux rétrovirus de type RNA.  1) Use of a homeopathic strain of insulinum to prepare homeopathic medicines for treating viral infections caused by Herpesviridae, papillomaviruses, and RNA retroviruses. 2 ) Utilisation d'une souche homéopathique d' insulinum selon la revendication i pour préparer des médicaments homéopathiques actifs notamment contre les affections suivantes: - ZONA Cutané - ZONA Ophtalmique - HERPES Labial ou Bouton de Fièvre - HERPES génital  2) Use of a homeopathic strain of insulinum according to claim i for preparing homeopathic medicines active in particular against the following conditions: - ZONA Dermal - ZONA Ophthalmic - HERPES Labial or Fever Button - GENITAL HERPES - VERRUES- GLASSES - INFECTIONS à RETROVIRUS de type RNA  - RNA RETROVIRUS INFECTIONS
FR0506208A 2005-06-20 2005-06-20 NEW USE OF A HOMEOPATHIC STRAIN FOR THE PREPARATION OF HOMEOPATHIC DRUGS, ACTIVE ON HERPES, ZONA, GLANDS AND ON RNA-TYPE RETROVIRUSES Expired - Fee Related FR2887151B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0506208A FR2887151B1 (en) 2005-06-20 2005-06-20 NEW USE OF A HOMEOPATHIC STRAIN FOR THE PREPARATION OF HOMEOPATHIC DRUGS, ACTIVE ON HERPES, ZONA, GLANDS AND ON RNA-TYPE RETROVIRUSES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0506208A FR2887151B1 (en) 2005-06-20 2005-06-20 NEW USE OF A HOMEOPATHIC STRAIN FOR THE PREPARATION OF HOMEOPATHIC DRUGS, ACTIVE ON HERPES, ZONA, GLANDS AND ON RNA-TYPE RETROVIRUSES

Publications (2)

Publication Number Publication Date
FR2887151A1 true FR2887151A1 (en) 2006-12-22
FR2887151B1 FR2887151B1 (en) 2009-07-03

Family

ID=35765997

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0506208A Expired - Fee Related FR2887151B1 (en) 2005-06-20 2005-06-20 NEW USE OF A HOMEOPATHIC STRAIN FOR THE PREPARATION OF HOMEOPATHIC DRUGS, ACTIVE ON HERPES, ZONA, GLANDS AND ON RNA-TYPE RETROVIRUSES

Country Status (1)

Country Link
FR (1) FR2887151B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026679A1 (en) * 1994-03-31 1995-10-12 Biomed Comm Incorporated Therapeutic homeopathic dilutions of growth factors and methods of their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026679A1 (en) * 1994-03-31 1995-10-12 Biomed Comm Incorporated Therapeutic homeopathic dilutions of growth factors and methods of their use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BECKER Y ET AL: "INSULIN INHIBITS CELLULAR AND HERPES SIMPLEX VIRUS DNA SYNTHESIS IN TRANSFORMED LYMPHO BLASTOID CELL LINES", INTERVIROLOGY, vol. 10, no. 6, 1978, pages 345 - 350, XP009061931, ISSN: 0300-5526 *
BOERICKE W.: "HOMOEOPATHIC MATERIA MEDICA", 17 February 2005 (2005-02-17), XP002368026, Retrieved from the Internet <URL:http://web.archive.org/web/20050217022111/http://www.homeoint.org/books/boericmm/i/ins.htm> [retrieved on 20060215] *

Also Published As

Publication number Publication date
FR2887151B1 (en) 2009-07-03

Similar Documents

Publication Publication Date Title
Sugimoto et al. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia
Bachis et al. Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons
MA33274B1 (en) DERIVATIVES OF THIENO [2,3-B] PYRIDINE AS INHIBITORS OF VIRAL REPLICATION
JP5699135B2 (en) Drugs for preventing and treating highly pathogenic infections
Mustafa et al. Herpes simplex virus infections, Pathophysiology and Management
Wodarski et al. Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy
Nelson et al. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection
SG170825A1 (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
WO2021211659A3 (en) Treatment for diseases caused by rna viruses
Sawalha Patients with lupus are not protected from COVID-19
MA38694B1 (en) Therapeutically active derivatives of estratriene thiazole substituted in position 17 as 17beta.-hydroxysteroid dehydrogenase inhibitors
FR2887151A1 (en) Use of a homeopathic insulinum stock (I) to prepare homeopathic medicaments to treat viral infections due to herpes virus, papilloma virus and retrovirus
RU2014151156A (en) NALMEPHEN TO REDUCE ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS
Ruocco et al. “Two‐step” pemphigus induction by ace‐inhibitors
WO2008068393A1 (en) Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses
Saral et al. Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in Molluscum lesions from a Turkish population
Zhang et al. Ketorolac tromethamine represses senescence in aging articular chondrocytes
Twigg The black death and DNA
US9084758B2 (en) Antiviral compositions comprising ethanol extract of Tetracera scandens and use thereof
Numan et al. Rabies out-break in mules at Mansehra, Pakistan
WO2010133652A1 (en) Multimodal activity of g-quartet oligonucleotides and microbicide compositions
Kaushik et al. Destabilization of tRNA3Lys from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog
Mayer NextGen HIV prevention: new possibilities and questions
Wray Essential dental therapeutics
Seoighe et al. Licking as an out-of-hospital burns treatment—An isolated cultural phenomenon?

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100226